NEWS & VIEWS

Global private equity and venture capital news and research

Posts Tagged ‘ARCH Venture Partners’

21 November 2016

Arch Venture Partners boosts Fund IX target after storming start to fundraise

ruin-1778575_1920 Arch Venture Partners has upped its sights for its latest venture fundraise after already passing the $400m it initially registered to raise, AltAssets can reveal.

25 April 2016

VC-backed Hua Medicine seals $50m Series C financing round

lump-sugar-549096_1920 Chinese diabetes and nervous system disorder therapy developer Hua Medicine has picked up a $50m venture capital-backed Series C round of financing.

18 March 2016

Arch Venture Partners primes new $400m fundraise

delicate-arch-4625_1920 Chicago-based early-stage investment firm Arch Venture Partners is back in the market targeting up to $400m for its ninth fund.

16 June 2015

Arch leads $30m in Aledade alongside return investor Venrock

spire healthcare Arch Venture Partners has led $30m Series B financing round in Aledade, a US company which looks to help doctors run small practices.

15 May 2015

Degenerative brain disease treatment company Denali launched with $217m VC backing

brain-001-880737-m A group of venture capital investors have helped launch degenerative brain disease treatment company Denali Therapeutics through a $217m investment.

15 April 2015

Company helping synthesise human vision nets $40m VC-backed funding round

eye A joint venture between Atlantic Bridge Capital and WestSummit Capital has led a $40m financing round for a tech business which aims to help companies implement visual sensing to mimic human sight.

12 March 2015

Kura Oncology closes $60m EcoR1 Capital-led round

download (76) EcoR1 Capital has led a $60m financing round in biopharmaceutical company in Kura Oncology.

22 December 2014

VC-backed Juno Therapeutics raises $264.5m at IPO

money-in-hand-1035691-m Arch Venture Partners-backed cancer fighting company Juno Therapeutics has raised $264.5m after pricing its shares at $24m.

28 October 2014

Syros lands $53m from eight VC firms

pills-pills-pills-4-606633-m Eight venture capital firms have participated in a $53m Series B financing round for gene control therapies company Syros Pharmaceuticals.

27 August 2014

Arch Venture Partners raises more than $400m for latest fund

chicagooo Chicago-based venture capital firm Arch Venture Partners has closed its eighth fund on more than $400m, easily beating its $250m target.

Page 1 of 3123

Legals & Terms of UsePrivacy Policy


AltAssets is registered as a trademark of Investor Networks Limited (06695690).
Registered Office: WeWork 4001, 1 Fore Street, London, EC2Y 5EJ
Content is © AltAssets 2000-2016